XML 47 R32.htm IDEA: XBRL DOCUMENT
v3.25.0.1

STOCKHOLDERS' DEFICIT (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Equity [Abstract] |
Schedule of Stock Options Outstanding and Stock Option Activity | The following table presents a summary of the Company's stock options outstanding at and stock option activity during the year ended December 31, 2024 ("Price" reflects the weighted average exercise price per share):
(In thousands, except per share data) | Options |  | Price |  | Weighted Average Remaining Contractual Term
Outstanding, January 1, 2024 | 7,188 |  |  | $ | 16.22 |  |  | 3.0 years
Granted | — |  |  |  |  |
Exercised | — |  |  |  |  |
Forfeited | (10) |  |  | 13.13 |  |  |
Expired | (208) |  |  | 16.56 |  |  |
Outstanding, December 31, 2024 | 6,970 |  |  | 16.21 |  |  | 2.1 years
Exercisable | 6,901 |  |  | 16.18 |  |  | 2.0 years
Expected to Vest | 69 |  |  | 19.36 |  |  | 6.3 years
Summary of Unvested Options and Changes | A summary of the Company's unvested options and changes during the year ended December 31, 2024 is presented below:
(In thousands, except per share data) | Options |  | Weighted Average Grant Date Fair Value
Unvested, January 1, 2024 | 639 |  |  | $ | 5.99 |
Granted | — |  |  |
Vested(1) | (559) |  |  | 5.44 |
Forfeited | (11) |  |  | 6.76 |
Unvested, December 31, 2024 | 69 |  |  | 10.37 |
(1)The total fair value of the options vested during the year ended December 31, 2024 was $3.0 million.
Summary of Restricted Stock Outstanding and Restricted Stock Activity | The following table presents a summary of the Company's RSUs outstanding and RSU activity as of and during the year ended December 31, 2024 (“Price” reflects the weighted average share price at the date of grant):
(In thousands, except per share data) | Awards |  | Price
Outstanding, January 1, 2024 | 11,611 |  |  | $ | 6.48 |
Granted | 4,863 |  |  | 2.08 |
Vested (restriction lapsed) | (3,051) |  |  | 6.07 |
Forfeited | (362) |  |  | 5.90 |
Outstanding, December 31, 2024 | 13,061 |  |  | 4.95 |
Schedule of Share-Based Payment Arrangement, Cost by Plan | The following table presents the Company's total share-based compensation expense by award type:
(In thousands) | Year Ended December 31,
| 2024 |  | 2023 |  | 2022
RSUs | $ | 20,783 |  |  | $ | 21,709 |  |  | $ | 21,048 |
Performance RSUs | 9,375 |  |  | 8,857 |  |  | 5,589 |
Options | 2,153 |  |  | 5,059 |  |  | 8,820 |
Total Share Based Compensation Expense(1) | $ | 32,311 |  |  | $ | 35,625 |  |  | $ | 35,457 |
(1) Total share based compensation expense includes $3.7 million and $1.0 million of expense from cash settled awards for the years ended December 31, 2024 and 2023, respectively. There was no expense from cash settled awards for the year ended December 31, 2022.
Schedule of Loss Per Share |
(In thousands, except per share data) | Year Ended December 31,
| 2024 |  | 2023 |  | 2022
NUMERATOR: |  |  |  |  |
Net loss attributable to the Company – common shares | $ | (1,009,941) |  |  | $ | (1,102,660) |  |  | $ | (264,663) |
DENOMINATOR(1): |  |  |  |  |
Weighted average common shares outstanding - basic | 151,272 |  |  | 149,255 |  |  | 148,058 |
Stock options and restricted stock(2): | — |  |  | — |  |  | — |
Weighted average common shares outstanding - diluted | 151,272 |  |  | 149,255 |  |  | 148,058 |
Net loss attributable to the Company per common share: |  |  |  |  |
Basic | $ | (6.68) |  |  | $ | (7.39) |  |  | $ | (1.79) |
Diluted | $ | (6.68) |  |  | $ | (7.39) |  |  | $ | (1.79) |
(1)All of the outstanding Special Warrants are included in both the basic and diluted weighted average common shares outstanding of the Company for the years ended December 31, 2024, 2023, and 2022. (2)Outstanding equity awards representing 15.1 million, 13.6 million and 11.0 million shares of Class A common stock of the Company for the years ended December 31, 2024, 2023, and 2022, respectively, were not included in the computation of diluted earnings per share because to do so would have been antidilutive.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (e)(1) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration